AD

drug

2 Results / Page 1 of 1

AD

Business & Lifestyle

Samsung releases its first biosimilar drug in U.S.

Danielle Haynes, United Press International Writer SEOUL, South Korea (UPI) -- Electronics giant Samsung made its first foray into U.S. pharmaceuticals Monday when it joined efforts with Merck to release a lower-cost version of a rheumatoid arthritis drug. Samsung Bioepis, a subsidiary of the South Korean producer of televisions and smartphones, and Merck Biosimilars released Renflexis, a version of Johnson & Johnson's Remicade. The U.S. Food and Drug Administration gave approval in April to the drug, which the companies said would be sold for […]

todayJuly 24, 2017 53

Business & Lifestyle

U.S. Supreme Court backs quicker approval of drug copies

Allen Cone United Press International WASHINGTON, D.C. (UPI) -- The U.S. Supreme Court unanimously ruled Monday that biotech drug copies -- called biosimilars -- can become available to consumers quicker. Writing for the court, Associate Justice Clarence Thomas said that the decision was not based on policy arguments, but rather, the "plain language" of the biosimilar statue itself. The nine justices overturned a lower court's decision that had prevented Swiss pharmaceutical company Novartis AG from selling its injectable version of […]

todayJune 12, 2017 85

AD

Heartland Media Group of Central Illinois & Eastern Missouri
107 W. State Street PO Box 149
Nokomis, IL 62075
Tel: (866) 420-7790

STAY CONNECTED

CHECK OUT OUR STATIONS

DEADLINES & PUBLICATION INFORMATION

Deadlines
News and sports submissions
: 11 p.m. Central
Advertising, legals, obituaries: 5 p.m. Central

Publication times
Late breaking news as it happens
Normal publication:
11 p.m. Central daily
Other news:
Published as it’s made available

AD
AD
AD
AD
AD